IP Library › Assignment 028194/0963
Patent Assignment
Reel/Frame 028194/0963

Assignment of Assignor's Interest

Recorded: 2012-05-11 Pages: 7
Assignors
O'DONNELL, FRANCIS, JR
Executed: 2012-01-10
SANTOS, CARLOS
Executed: 2012-01-10
BONITZ, SUSAN
Executed: 2012-02-01
Assignee
ACCENTIA BIOPHARMACEUTICALS, INC.
324 SOUTH HYDE PARK AVENUE, SUITE 350, TAMPA, FLORIDA, 33606
Covered Properties (4)
Use of High-Dose, Post-Transplantation Oxazaphosphorine Drugs for Reduction of Transplant Rejection
Use of High Dose, Post-Transplantation Oxazaphosphorine Drugs for Reduction of Transplant Rejection
Application: 12/841,854 →
Use of High-Dose, Post-Transplantation Oxazaphosphorine Drugs for Reduction of Transplant Rejection
Application: 13/034,222 →
Use of High-Dose, Post-Transplantation Oxazaphosphorine Drugs for Reduction of Transplant Rejection
Application: 13/272,864 →
Publication: US 2012/0148577
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 11, 2012
From: FUCHS, EPHRAIM J.; LUZNIK, LEO; BRODSKY, ROBERT A.; JONES, RICHARD J.
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 028195/0030 →
Certificate of Title Oct 21, 2014
From: ACCENTIA BIOPHARMACEUTICALS, INC.
To: PABETI, INC.
Reel/Frame 034029/0770 →
Confirmatory License Sep 13, 2018
From: THE JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 046868/0648 →
Confirmatory License Oct 20, 2018
From: THE JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047246/0875 →
Confirmatory License Dec 15, 2018
From: THE JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047789/0001 →